Tackling Low Medication Supplies
and Disruptions in the Supply Chain
Amidst the COVID-19 Pandemic
Tackling Low Medication Supplies and Disruptions in the Supply Chain Amidst the COVID-19 Pandemic
Accessing medications that are safe, effective, and of high quality is multifaceted and requires having several necessary tools at hand.
By having better policies and information-sharing, institutions and professionals will be better equipped to create initiatives and/or safeguards that target the most pressing issues.
To foster sustainable innovation, engage with diverse stakeholders and leverage technology.
Evaluating and creating processes and plans are critical strategies of any institution.
Last year, Dr. Kaakeh gave a TEDx titled “The Struggle to Access Medications,” where she shared eight key lessons highlighting what we need moving forward as we tackle the issue of lack of access to medications. This was conducted before COVID-19; however, these lessons still hold true today. The eight lessons are outlined below.
Several factors should be taken into account in attempts to understand the real impact on the supply chain.
Delivery of materials and products, workforce capabilities, and the availability of complete information remain a significant concern.
Fluctuations in the pharmaceutical supply chain can lead to access and safety concerns.
The pharmaceutical supply chain is global and sensitive to disruptions worldwide.
Any medication may be susceptible to a shortage; however, medications used during intensive and emergency care are particularly vulnerable during this time.
The impact on patient care, safety, operations, and costs caused by drug shortages are intensified during crises.
With hundreds of medications already in short supply, global crises (like COVID-19) create additional burden on the supply chain.
Medications play an instrumental role in the prevention and treatment of many diseases, yet billions still lack access.